Cobalis
Cobalis Corp.: Specialty pharma firm developing treatments for atopic diseases and allergy prevention.
- 6
- Series B
Founded with a mission to develop innovative treatments for atopic diseases, Cobalis Corp. is a specialty pharmaceutical company focused on preventing and treating conditions such as allergies, migraine headaches, atopic asthma, and dermatitis. Their flagship product, PreHistin, is an allergy prevention medication currently in Phase III clinical development. Cobalis aims to secure FDA approval to market PreHistin as an over-the-counter medication in the United States.
Cobalis has garnered attention from notable investors and industry experts who recognize the potential impact of their groundbreaking work. The company's key achievements include advancing PreHistin through critical phases of clinical trials, positioning it as a promising solution for allergy sufferers. By focusing on unmet medical needs in the atopic disease market, Cobalis is poised to make significant contributions to improving patient outcomes and quality of life.
Similar Companies
CoLabs
colabsintl.com
Corbus Pharmaceuticals Holdings
corbuspharma.com
Tunitas Therapeutics
ClostraBio
clostrabio.com
Prevacus
Corsair Pharma
corsairpharma.com
Accuitis
accuitis.com
Optinose
optinose.com
Collegium Pharmaceutical
Allermi
Prevention Pharmaceuticals
Bryn Pharma
brynpharma.com
Epalex
epalex.com
Osprey Pharmaceuticals USA
ospreypharma.com
Bordeaux Laboratories
bordeauxlabs.com
Quick Facts
Who are Cobalis' competitors?
Companies similar to Cobalis include CoLabs, Corbus Pharmaceuticals Holdings, Tunitas Therapeutics and ClostraBio.
When was Cobalis founded?
Cobalis was founded in 1997.
Where is Cobalis' headquarters located?
Cobalis' headquarters is located in Irvine, CA, US.
When was Cobalis' last funding round?
Cobalis' most recent funding round was for $3.9M (USD) in February 2007.
How much disclosed funding has Cobalis raised?
As of Feb 22, 2007, Cobalis has disclosed funding of $6.3M (USD). Undisclosed round amounts are excluded.
How many employees does Cobalis have?
Cobalis has 6 employees as of Feb 5, 2024.
Classification
- Ownership
- Technology
- Geographic Exposure
- Customer
- Main Product
- NAICS
- 540000Professional, Scientific, and Technical Services
- 541714Research and Development in Biotechnology (except Nanobiotechnology)
- 541000Professional, Scientific, and Technical Services
- 541700Scientific Research and Development Services
- 541710Research and Development in the Physical, Engineering, and Life Sciences
- SIC
- 2800Chemicals And Allied Products
- 2830Drugs
- 2834Pharmaceutical Preparations
- ISIC
- 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 16 more industry codes
- NAICS
- 320000Manufacturing
- 325400Pharmaceutical and Medicine Manufacturing
- 620000Health Care and Social Assistance
- 325000Chemical Manufacturing
- 623000Nursing and Residential Care Facilities
- 325410Pharmaceutical and Medicine Manufacturing
- 325412Pharmaceutical Preparation Manufacturing
- SIC
- 5600Apparel And Accessory Stores
- 4000Railroad Transportation
- 5000Wholesale Trade-durable Goods
- 8000Health Services
- 8700Engineering, Accounting, Research, Management, And Related Services
- 8040Offices And Clinics Of Other Health Practitioners
- 8730Research, Development, And Testing Services
- 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
- 8731Commercial Physical and Biological Research